chr17:39724738:A>TGGCTGG Detail (hg38) (ERBB2)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr17:37,880,991-37,880,991 View the variant detail on this assembly version. |
hg38 | chr17:39,724,738-39,724,738 |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_004448.3:c.2320delinsTGGCTGG | NP_004439.2:p.Met774delinsTrpLeuVal |
NM_001289937.1:c.2320delinsTGGCTGG | NP_001276866.1:p.Met774delinsTrpLeuVal | |
NM_001005862.2:c.2230delinsTGGCTGG | NP_001005862.1:p.Met744delinsTrpLeuVal |
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
lung non-small cell carcinoma | Dacomitinib | C |
![]() |
![]() |
Sensitivity/Response | Somatic | 3 | 25899785 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
Phase 2 trial of ERBB-inhibitor dacomitinib in stage IIIB/IV lung cancers with HER2 mutations or amp... | CIViC Evidence | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- Genome
- hg38
- Position
- chr17:39,724,738-39,724,738
- Variant Type
- snv
- Reference Allele
- A
- Alternative Allele
- TGGCTGG
- Variant (CIViC) (CIViC Variant)
- M774DELINSWLV
- Transcript 1 (CIViC Variant)
- ENST00000269571.5
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/818
Genome browser